Previous 10 | Next 10 |
Corbus Pharmaceuticals (NASDAQ: CRBP ) -75% after announcing topline results from RESOLVE-1 study of Lenabasum. More news on: Corbus Pharmaceuticals Holdings, Inc., PolyMet Mining Corp., Tesla, Inc., Stocks on the move, , Read more ...
Gainers: PolyMet Mining (NYSEMKT: PLM ) +83% . More news on: PolyMet Mining Corp., VivoPower International PLC, FBL Financial Group, Inc., Stocks on the move, , Read more ...
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in investo...
Shares of Fluidigm (NASDAQ: FLDM) plummeted on Thursday after a powerful rival announced a major development in the COVID-19 diagnostic race. What a difference a day makes. After soaring 30% on Wednesday following news that its saliva-based coronavirus test had received an emergency us...
The Nasdaq Composite (NASDAQINDEX: ^IXIC) has been the standout winner in the U.S. stock market so far in 2020, but it can't keep up the pace every single day. With market participants paying close attention to the Federal Reserve's latest pronouncement on how it intends to manage monetary p...
Gainers: VBI Vaccines (NASDAQ: VBIV ) +35% . More news on: VBI Vaccines Inc., Rekor Systems, Inc., BMC Stock Holdings, Inc., Stocks on the move, , Read more ...
Cocrystal Pharma (NASDAQ: COCP ) -25% after raising "bought deal" offering to $15M. More news on: Cocrystal Pharma, Inc., SunPower Corporation, Quidel Corporation, Stocks on the move, , Read more ...
Shares of Fluidigm (NASDAQ: FLDM) soared on Wednesday after the biotechnology tools provider said its new saliva-based test for SARS‑CoV‑2 -- the virus that causes COVID-19 -- received emergency use authorization from the U.S. Food and Drug Administration (FDA). As of 1:13...
Gainers: Fluidigm Corporation (NASDAQ: FLDM ) +33% . More news on: Fluidigm Corporation, SCWorx Corp., Anaplan, Inc., Stocks on the move, Read more ...
Tyme Technologies (NASDAQ: TYME ) +29% as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. More news on: Tyme Technologies, Inc., SCWorx Corp., Immunic, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...